Vice President, Medical Affairs
Alumis
| Company | Alumis |
| Category | Healthcare |
| Location | South San Francisco |
| Remote | On-site (inferred) |
| Employment | Not stated |
| Level | Executive |
| Salary | Not stated by the employer |
| Posted | 26 Jan 2026 |
| Last verified | 10 Aug 2026 |
| Source | Employer ATS (greenhouse) |
Description
Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer - our goal is to fundamentally change the outcomes for these patients. We have recently completed our pivotal trials of envudeucitinib, our second-generation tyk2 inhibitor in moderate to severe plaque psoriasis and expect results from a potentially pivotal Phase 2b trial in SLE in the third quarter of 2026.
As a key member of the Alumis team, you will provide overall leadership for the Medical Affairs function, overseeing Medical Affairs, Field Medical Liaisons, and publications. The position will liaise closely with the clinicians responsible for carrying out Alumis’ clinical studies as well as our commercial group. Applicants should be a “leader/doer” capable of generating strategies and leading cross functionally. This VP, Medical Affairs will report directly to the Chief Medical Officer.
Responsibilities
Lead the Medical Affairs function at Alumis
Develop and implement key Medical Affairs strategies and activities to support the development of our lead assets
Continue to build and scale the Medical Affairs organization
Develop and present Medical Affairs operational plans to Development and Executive management
Represent company externally
Direct and oversee all aspects of Medical Affairs and pre-launch needs
Lead medical launch preparations for our lead Psoriasis candidate, ensuring the scientific narrative is robust and well-vetted.
As a member of the Development Leadership Team, run and continue to build the Medical Affairs function
Build and lead a best-in-class global medical affairs team to support launches of multiple indications with a focus on psoriasis for our lead asset, envudeucitinib
Develop key performance indicators and generate analytical reports related to Medical Affairs plans and Medical Science Liaison group activities
Develop and implement Medical Communication and Disease State Awareness strategies
Partner with KOLs to gather information on current focused therapeutic area issues and questions
Collaborate with the Commercial team to develop educational material for providers and patients that are balanced and medically accurate
Provide direction and input into the development and implementation of successful reimbursement and market-access strategies
Work closely with the members of the clinical development and commercial leadership teams to develop the overall strategic direction for Alumis, evaluate alternative strategies, identify competitive issues, and develop and implement operating plans to achieve company objectives
Foster collaborative relationships with academic and clinical experts, publishers, medical and patient associations, and other relevant external and internal stakeholders
Develop and manage departmental budgets that effectively achieve desired goals and are balanced with the financial objectives of the broader organization
Oversee the publication strategy, ensuring clinical data is presented at major congresses (e.g., AAD, EADV, ACR) and in high-impact peer-reviewed journals.
Education | Experience | Skill Requirements
10+ years of professional experience within Biotech/Pharma in Medical Affairs
5+ years of people leadership experience
An understanding of government and industry guidelines, regulations, laws, etc., for appropriate scientific/medical exchange and communication with customers
Ability to lead by example, attract and develop talent, build interdependent partnerships, and create a culture of collaboration and teamwork that fosters open communication, constructive conflict resolution and organizational flexibility&nbs